PVH Corp
PVH
78.33
+0.12
+0.15%
PVH Corp
US · PVH
#2397 by market cap
Listed 1970
78.33
+0.12
+0.15%
Live - 5344 symbols - heartbeat 213s ago
· 2026-10-08 07:46
Pre-market
77.55
-1.00%
After-hours
78.33
0.00%
Overnight
78.30
-0.04%
- Market cap
- 3.61B
- P/E (TTM)i
- -23.11
- P/Bi
- 0.75
- EPSi
- 0.52
- Div yieldi
- 0.19%
- 52W posi
- 46%
Reader sentiment
Are you bullish or bearish on PVH?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Fair
- Altman Z-Score is 2.11, in the 1.8-3.0 "grey zone".
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +3.44% YoY
Margins
- Gross margin
- 57.53%
- Operating margin
- 7.34%
- Net margin
- 0.28%
Key ratios & quality
- Enterprise valuei
- 5.56B
- Altman Z-Scorei
- 2.11
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 9.66B | 9.91B | 7.13B | 9.15B | 9.02B | 9.22B | 8.65B | 8.95B |
| Gross profit | 5.31B | 5.39B | 3.78B | 5.32B | 5.12B | 5.36B | 5.14B | 5.15B |
| Selling & admin expenses | 4.43B | 4.72B | 3.98B | 4.45B | 4.38B | 4.54B | 4.41B | 4.49B |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 875.50M | 673.20M | -206.40M | 870.20M | 745.50M | 820.60M | 731.20M | 656.50M |
| Pretax profit | 775.60M | 444.00M | -1.19B | 972.70M | 388.20M | 841.00M | 705.70M | 151.30M |
| Tax | 31.00M | 28.90M | -55.50M | 20.70M | 187.80M | 177.40M | 107.20M | 126.00M |
| Net profit | 744.60M | 415.10M | -1.14B | 952.00M | 200.40M | 663.60M | 598.50M | 25.30M |
| Basic EPS | 10 | 6 | -16 | 13 | 3 | 11 | 11 | 1 |
| Diluted EPS | 9.65 | 5.60 | -15.96 | 13.25 | 3.03 | 10.76 | 10.56 | 0.52 |
| Line item | 2025-05 | 2025-08 | 2025-11 | 2026-01 | 2026-05 | 2026-08 |
|---|---|---|---|---|---|---|
| Revenue | 1.98B | 2.17B | 2.29B | 2.51B | 2.03B | 2.10B |
| Gross profit | 1.16B | 1.25B | 1.29B | 1.44B | 1.19B | 1.32B |
| Selling & admin expenses | 1.02B | 1.13B | 1.12B | 1.22B | 1.07B | 1.11B |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 137.80M | 121.90M | 171.80M | 225.00M | 111.80M | 209.30M |
| Pretax profit | -349.60M | 111.20M | 160.30M | 229.40M | 108.50M | -202.60M |
| Tax | -304.80M | -113.00M | 156.10M | 387.70M | 20.50M | -99.70M |
| Net profit | -44.80M | 224.20M | 4.20M | -158.30M | 88.00M | -102.90M |
| Basic EPS | -1 | 5 | 0 | -3 | 2 | -2 |
| Diluted EPS | -0.88 | 4.63 | 0.09 | -3.46 | 1.90 | -2.23 |
Balance sheet
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 3.24B | 3.39B | 3.94B | 3.65B | 3.58B | 3.26B | 3.49B | 3.61B |
| Cash & ST investments | 452.00M | 503.40M | 1.65B | 1.24B | 550.70M | 707.60M | 748.00M | 701.50M |
| Inventory | 1.73B | 1.62B | 1.42B | 1.35B | 1.80B | 1.42B | 1.51B | 1.58B |
| Total assets | 11.86B | 13.63B | 13.29B | 12.40B | 11.77B | 11.17B | 11.03B | 11.68B |
| Total current liabilities | 1.89B | 2.36B | 2.58B | 2.79B | 2.77B | 2.77B | 2.74B | 2.38B |
| Short-term debt | 12.80M | 426.90M | 462.50M | 421.00M | 511.80M | 866.40M | 799.90M | 359.70M |
| Long-term debt | 2.82B | 2.69B | 3.51B | 2.32B | 2.18B | 1.59B | 1.58B | 2.29B |
| Total liabilities | 6,035,700,000.00 | 7,821,500,000.00 | 8,566,600,000.00 | 7,108,000,000.00 | 6,755,600,000.00 | 6,054,000,000.00 | 5,892,700,000.00 | 6,888,700,000.00 |
| Total equity | 5.83B | 5.81B | 4.73B | 5.29B | 5.01B | 5.12B | 5.14B | 4.79B |
| Retained earnings | 4.35B | 4.75B | 3.61B | 4.56B | 4.75B | 5.41B | 6.00B | 6.02B |
| Line item | 2025-05 | 2025-08 | 2025-11 | 2026-01 | 2026-05 | 2026-08 |
|---|---|---|---|---|---|---|
| Total current assets | 3.03B | 3.30B | 3.28B | 3.61B | 3.38B | 3.98B |
| Cash & ST investments | 191.00M | 248.80M | 158.20M | 701.50M | 592.50M | 965.90M |
| Inventory | 1.60B | 1.79B | 1.66B | 1.58B | 1.51B | 1.74B |
| Total assets | 10.67B | 11.63B | 11.42B | 11.68B | 11.34B | 11.42B |
| Total current liabilities | 2.73B | 2.41B | 2.24B | 2.38B | 2.01B | 2.42B |
| Short-term debt | 921.20M | 342.40M | 352.80M | 359.70M | 352.50M | 360.80M |
| Long-term debt | 1.72B | 2.26B | 2.25B | 2.29B | 2.27B | 2.24B |
| Total liabilities | 6,054,200,000.00 | 6,761,000,000.00 | 6,542,200,000.00 | 6,888,700,000.00 | 6,446,900,000.00 | 6,624,700,000.00 |
| Total equity | 4.62B | 4.87B | 4.88B | 4.79B | 4.89B | 4.79B |
| Retained earnings | 5.95B | 6.17B | 6.17B | 6.02B | 6.10B | 6.00B |
Cash flow
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 852.50M | 1.02B | 697.70M | 1.07B | 39.20M | 969.40M | 740.90M | 680.40M |
| Depreciation & amortization | 334.80M | 323.80M | 325.80M | 313.30M | 301.50M | 298.60M | 282.20M | 272.30M |
| Free cash flow | 473.00M | 675.10M | 471.10M | 803.30M | -250.90M | 724.70M | 582.20M | 538.40M |
| Dividends paid | -11.60M | -11.30M | -2.70M | -2.70M | -10.10M | -9.40M | -8.60M | -7.50M |
| Stock buybacks / issuance | -325.20M | -345.10M | -117.30M | -361.30M | -418.60M | -570.30M | -524.80M | -577.70M |
| Ending cash balance | 452.00M | 503.40M | 1.65B | 1.24B | 550.70M | 707.60M | 748.00M | 701.50M |
| Line item | 2025-05 | 2025-08 | 2025-11 | 2026-01 | 2026-05 | 2026-08 |
|---|---|---|---|---|---|---|
| Operating cash flow | -71.40M | 213.10M | -44.50M | 583.20M | -46.50M | 382.90M |
| Depreciation & amortization | 67.70M | 68.70M | 69.40M | 66.50M | 62.60M | 57.30M |
| Free cash flow | -98.10M | 181.90M | -85.10M | 539.70M | -86.00M | 346.40M |
| Dividends paid | -1.90M | -2.00M | -1.80M | -1.80M | -1.80M | -1.70M |
| Stock buybacks / issuance | -572.20M | -4.80M | -200.00K | -500.00K | -14.90M | -2.00M |
| Ending cash balance | 191.00M | 248.80M | 158.20M | 701.50M | 592.50M | 965.90M |
Returns & efficiency
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 13.14 | 7.17 | -21.55 | 19.01 | 3.89 | 13.10 | 11.67 | 0.51 |
| ROA %i | 6.29 | 3.27 | -8.44 | 7.41 | 1.66 | 5.79 | 5.39 | 0.22 |
| ROIC %i | 9.93 | 5.49 | -9.91 | 10.88 | 2.89 | 8.38 | 7.62 | 0.83 |
| 5-year avg ROE %i | 11.64 | 11.06 | 4.18 | 5.63 | 4.33 | 4.32 | 5.22 | 9.64 |
| EBIT margin %i | 9.28 | 5.69 | -14.97 | 11.81 | 5.29 | 10.20 | 9.19 | 2.74 |
| FCF / sales %i | 4.90 | 6.81 | 6.60 | 8.77 | -- | 7.86 | 6.73 | 6.02 |
| Current ratioi | 1.71 | 1.44 | 1.53 | 1.31 | 1.29 | 1.18 | 1.27 | 1.52 |
| Quick ratioi | 0.66 | 0.54 | 0.90 | 0.72 | 0.54 | 0.55 | 0.59 | 0.72 |
| Debt / assetsi | 23.87 | 34.13 | 40.67 | 31.89 | 32.53 | 31.63 | 30.74 | 36.80 |
| LT debt / equityi | 48.38 | 72.72 | 104.53 | 66.78 | 66.17 | 52.11 | 50.41 | 82.20 |
| Interest coveragei | 7.42 | 4.70 | -8.51 | 9.96 | 5.33 | 9.47 | 8.86 | 2.61 |
| Revenue CAGR (3Y) %i | 6.39 | 6.50 | -7.16 | -1.76 | -3.07 | 8.92 | -1.86 | -0.27 |
| Net income CAGR (3Y) %i | 9.25 | -8.74 | -- | 8.46 | -21.69 | -- | -14.34 | -49.83 |
| FCF CAGR (3Y) %i | -9.65 | 0.96 | 18.09 | 19.31 | -- | 15.44 | -10.17 | -- |
| Line item | 2025-05 | 2025-08 | 2025-11 | 2026-01 | 2026-05 | 2026-08 |
|---|---|---|---|---|---|---|
| ROE %i | 8.31 | 9.32 | 6.70 | 0.51 | 3.32 | -3.50 |
| ROA %i | 3.75 | 4.10 | 3.01 | 0.22 | 1.44 | -1.47 |
| ROIC %i | 5.32 | 5.81 | 4.41 | 0.83 | 2.34 | -1.42 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 2.97 | 2.47 | 2.39 | 2.74 | 7.83 | 4.33 |
| FCF / sales %i | 6.79 | 5.88 | 5.01 | 6.02 | 6.12 | 8.01 |
| Current ratioi | 1.11 | 1.37 | 1.47 | 1.52 | 1.68 | 1.65 |
| Quick ratioi | 0.39 | 0.48 | 0.57 | 0.72 | 0.75 | 0.79 |
| Debt / assetsi | 34.95 | 36.86 | 37.27 | 36.80 | 37.24 | 36.46 |
| LT debt / equityi | 60.81 | 81.03 | 80.02 | 82.20 | 79.10 | 79.34 |
| Interest coveragei | 2.90 | 2.36 | 2.29 | 2.61 | 7.45 | 4.25 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Lead segment, long tail
- Europe, the Middle East and Africa (EMEA) is the largest reported line at 47.03% of revenue, across 4 reported segments.
- Americas follows at 32.43%, so the top line still matters most but isn’t the whole story.
Revenue breakdown most recent period
Business
Europe, the Middle East and Africa (EMEA)47.03%
Americas32.43%
Asia-Pacific (APAC)16.39%
Licensing4.14%
Quote time 2026-10-08 07:46:14 · For reference only, not investment advice and not tailored to your situation.